Enwei Pharmaceutical Co EBITDA

Que fait Enwei Pharmaceutical Co ? Enwei Pharmaceutical Co Ltd is a pharmaceutical company based in Chengdu, China, operating within the Health Care sector. The company specializes in the research and development, production, and sales of proprietary Chinese and chemical medicines. It went public on the Shenzhen Stock Exchange on September 21, 2022, with the ticker symbol 301331.SZ. Enwei Pharmaceutical currently employs 1,610 full-time staff. The company focuses on several key therapeutic areas, including gynecological products, pediatric medicines, and respiratory medicines. Its product portfolio includes Jieeryin lotion, Jieeryin ointment, Jieeryin effervescent tablets, Shanmai Jianpi oral liquid, Qingjing capsules, and Danxiong Tongmai granules. These products are distributed through direct sales channels and e-commerce platforms. Enwei Pharmaceutical primarily serves the domestic Chinese market, with no indication of significant international operations. The company's headquarters are located in Chengdu, Sichuan Province, and it maintains a corporate website at https://www.enwei.com.cn/index.html. The firm's business model centers on developing and commercializing its range of pharmaceutical products, targeting specific medical needs within China's healthcare system. The company's operations are structured around its research, production, and sales activities, with a clear emphasis on its core product lines. Enwei Pharmaceutical's market presence is defined by its focus on domestic distribution and its specialization in the specified therapeutic areas. Enwei Pharmaceutical Co est l'une des entreprises les plus populaires sur Eulerpool.